McKesson Corporation (MCK)
McKesson Bets on Oncology, Biopharma as It Streamlines Portfolio
MCK is transforming from a traditional distributor into a specialty-driven healthcare solutions leader, focusing on oncology, biopharma services and automation while preparing to separate its Medical-Surgical unit.
Will McKesson (MCK) Beat Estimates Again in Its Next Earnings Report?
McKesson (MCK) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade
In the closing of the recent trading day, McKesson (MCK) stood at $738.06, denoting a -2.72% move from the preceding trading day.
Here is What to Know Beyond Why McKesson Corporation (MCK) is a Trending Stock
Zacks.com users have recently been watching McKesson (MCK) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
McKesson (MCK) Rises Higher Than Market: Key Facts
The latest trading day saw McKesson (MCK) settling at $698.31, representing a +1.19% change from its previous close.
Drug distributor McKesson to restructure segments to focus on high-margin businesses
McKesson said on Thursday it will restructure its operations into four main segments from the current quarter as the U.S. drug distributor aims to focus on high-margin businesses such as cancer medicines to boost growth.
Is Trending Stock McKesson Corporation (MCK) a Buy Now?
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
McKesson Corporation (MCK) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to McKesson (MCK). This makes it worthwhile to examine what the stock has in store.
Here's Why McKesson (MCK) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
MCK Stock Down Despite Q1 Earnings Beat & Raised '26 EPS View
McKesson beats on Q1 earnings and raises FY26 EPS view, but shares slip as gross margin narrows and spin-off plans weigh on investors' sentiment.
Compared to Estimates, McKesson (MCK) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for McKesson (MCK) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
McKesson Corporation (MCK) Q1 2026 Earnings Call Transcript
McKesson Corporation (NYSE:MCK ) Q1 2026 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Brian S. Tyler - CEO & Director Britt J.
